A Study of Isatuximab-based Therapy in Participants With Lymphoma
Clinical trial NCT03769181 · TERMINATED
Trial details
- NCT number
- NCT03769181
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-11
- Primary completion
- 2022-11-08
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.